GHRP‑2 (Pralmorelin) is a synthetic peptide classified as a Growth Hormone-Releasing Peptide (GHRP). It works by activating ghrelin receptors, stimulating the natural release of growth hormone (GH) and increasing levels of IGF‑1. Due to these properties, GHRP‑2 has been examined in medical research for its potential to support growth hormone deficiency, improve body composition, and aid recovery.

This product contains 5 mg of lyophilized peptide per vial, intended for reconstitution prior to use under professional supervision.

Applications / Uses (informational only)

GHRP‑2 has been studied for potential benefits such as:

• Supporting lean muscle development

• Promoting fat reduction as part of metabolic research

• Enhancing post-exercise recovery

• Supporting bone density

• Potential anti-aging properties related to GH pathways

• Improving sleep quality

• Stimulating appetite due to ghrelin‑mimicking activity

These uses refer to clinical and research contexts only.

Effects

Reported physiological effects associated with GHRP‑2 include:

• Increased natural GH release

• Elevated IGF‑1 levels

• Improved muscle tissue repair

• Enhanced metabolic rate

• Strengthened connective tissue and bone health

• Support for restful sleep cycles

Individual responses vary and depend on professional medical oversight.

Possible Side Effects

Although GHRP‑2 is generally considered well‑tolerated in studies, potential side effects may include:

• Increased appetite

• Temporary bloating or water retention

• Mild tingling or numbness in extremities

• Possible impact on insulin sensitivity

• Potential elevation of cortisol or prolactin levels

Monitoring by qualified professionals is recommended during any medical or research use.

Safety Notes

• Intended for research and medical environments only

• Not approved for casual or recreational enhancement

• Should be used under professional supervision

• Monitoring of blood glucose, hormones, and general biomarkers is advised

For full product details and availability, visit www.cartelunited.eu.